Psoriasis: IL-17A-Antikörper Garantieren Raschen Wirkeintritt

hautnah dermatologie
doi 10.1007/s15012-017-2461-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Psoriasis: Dreifacher Erfolg Für IL-17-Antikörper

hautnah dermatologie
2016English

Secukinumab: First IL-17A Antagonist for Plaque Psoriasis

Pharmacy Today
2015English

IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A

Journal of Immunology
AllergyImmunology
2010English

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications

Frontiers in Immunology
AllergyImmunology
2020English

Psoriasis and the MAITing Game: A Role for IL-17A+ Invariant TCR CD8+ T Cells in Psoriasis?

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2014English

Transcriptome Profiling Unveils the Role of Cholesterol in IL-17A Signaling in Psoriasis

Scientific Reports
Multidisciplinary
2016English

Mannan Induces ROS-regulated, IL-17A-dependent Psoriasis Arthritis-Like Disease in Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

310 Unopposed IL-36 Activity Promotes Clonal CD4 + T-Cell Responses With IL-17A Production in Generalized Pustular Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Meta-Analysis of RNA Sequencing Datasets Reveals an Association Between TRAJ23, Psoriasis, and IL-17A

JCI insight
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy